A study called REDUCE-AMI found that using beta-blockers after a heart attack with preserved ejection fraction does not offer any benefits. This trial suggests that continuing to use beta-blockers in this specific situation may not be necessary. The study emphasizes the importance of personalized medicine and tailoring treatment plans to individual patients. The results of this trial may lead to a reconsideration of the use of beta-blockers in patients with preserved ejection fraction after a heart attack. Cookies are used on the website for analytics, advertising, and site improvement.
Source link
Beta-blocker use after MI and preserved ejection fraction offers no benefit: REDUCE-AMI trial
